A proof-of-concept study suggests that combines AI and the whole-genome sequencing of tumors could scale precision medicine for cancer.

Science Exchange will offer IndieBio-backed biotech startups access to its outsourced R&D platform.

Neuroscience-focused digital technology company Ixico just nabbed a contract for imaging clinical trial services from Spanish biotech Araclon.

Science Exchange has raised $28 million in its third funding round.

Parexel has become the latest CRO to be bought up as the industry continues its M&A bonanza.

LabConnect has received a healthy $24.5 million in its first equity investment.

Probably hoping to help turn things around after clinical setbacks, microRNA biotech Regulus tapped the help of CRO Aptuit.

Eisai and partner Charles River have clearly enjoyed their two-year R&D deal, as the pharma-CRO pair have signed up to extend that partnership for another…